A multi-centre, double-blind, placebo-controlled, randomised trial of combination methotrexate and gefitinib versus methotrexate alone to treat tubal ectopic pregnancies (GEM3): trial protocol

BACKGROUND: Tubal ectopic pregnancy (tEP) is the most common life-threatening condition in gynaecology. Treatment options include surgery and medical management. Stable women with tEPs with pre-treatment serum human chorionic gonadotrophin (hCG) levels < 1000 IU/L respond well to outpatient medic...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Trials
Главные авторы: May, James, Duncan, Colin, Mol, Ben, Bhattacharya, Siladitya, Daniels, Jane, Middleton, Lee, Hewitt, Catherine, Coomarasamy, Arri, Jurkovic, Davor, Bourne, Tom, Bottomley, Cecilia, Peace-Gadsby, Alexandra, Doust, Ann, Tong, Stephen, Horne, Andrew W.
Формат: Artigo
Язык:Inglês
Опубликовано: BioMed Central 2018
Предметы:
Study Protocol
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6247635/
https://ncbi.nlm.nih.gov/pubmed/30458863
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-018-3008-6
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы